Artificial Pancreas: First Clinical Trials in Argentina.

RICARDO SANCHEZ PEÑA; PATRICIO COLMEGNA; GROSEMBACHER, LUIS; BRETON, MARC; FABRICIO GARELLI; HERNÁN DE BATTISTA; BELLOSO, WALDO H.; CHERÑAVVSKY, DANIEL

Toulusse

Congreso; 20th World Congress of the International Federation of Automatic Control, IFAC-WC 2017; 2017

IFAC

The first clinical trials using an Articial Pancreas (AP) in Latin America have beendened in 2 stages. The first stage was carried out in November 2016 with the UVA controller(developed by the Center for Diabetes Technology and already clinically tested), and the secondwill be performed during the first semester of 2017 with the ARG (Automatic Regulation of Glucose) algorithm (developed by ITBA, UNQ, and UNLP in Argentina). Both tests are based on the DiAs (Diabetes Assistant) from the UVA, and are performed in the HIBA on 5 patientswith Type 1 Diabetes Mellitus (T1DM), for 36 hours. For the first stage, Open-Loop (OL)insulin boluses were applied before meals and patient´s physical activity was included. On the other hand, for the second stage, patients will not be involved in physical activity, but no OL insulin boluses will be injected before meals. In this work, experimental results from the rststage with the UVA controller, and preliminary results with the ARG control algorithm testedon the UVA/Padova simulator are presented. Due to the nal paper deadline, the experimental results from the second stage are not included here, but will be presented at the IFAC World Congress.